FRIZ Biochem GmbH is a privately owned biotechnology company specializing in the development, production, and distribution of high-quality molecular diagnostic products. With a strong commitment to scientific excellence and customer satisfaction, we have established ourselves as a trusted partner in the life sciences industry.
Since 2004 we have grown steadily and gained recognition for our cutting-edge technologies. Our product portfolio encompasses a wide range, catering to various needs and applications.
CYCLE® Dx: a fully automated, portable MDx platform for multiparametric and rapid PoC-Testing for viral and bacterial applications. The high level of automation facilitates the generation of reliable, PCR-based test results directly from unprocessed patient sample(s) in less than 30 minutes. Utilising an easy, plug&play workflow, operating the system is most simple and can be done with little to no specialist knowledge or training.
Lab direct qPCR kits: automation compliant, fast, and sensitive multiplex pathogen analysis directly from unprocessed patient sample(s) without complicated multi-step protocols for sample preparation or qPCR setup.
Chemicals: Oligonucleotides, phosphoramidites and functionalised nanoparticles with a variety of modifications for superior applications.
These products find applications in various fields of R&D as well as clinical/laboratory diagnostics.
Additionally, we invest significantly in innovation, constantly seeking to develop groundbreaking technologies. Our dedicated team of scientists, researchers, and technicians works collaboratively to create novel biochemical solutions that meet the evolving needs of the scientific community.
Furthermore, we are committed to sustainability and responsible business practices. We recognize the importance of minimizing our environmental impact and adopt measures to reduce waste, conserve resources, and operate in an eco-friendly manner.
Overall, we are driven by our dedication to scientific advancement, exceptional product quality, and a customer-centric approach. As we continue to grow and innovate, we aim to make significant contributions to the life sciences community and shape the future of molecular diagnostics.
frizbiochem.de